Cheaper prices slow down pharma market growth

The Swiss pharmaceutical market increased in value by 3.4 per cent last year, reaching almost SFr4.9 billion ($4.71 billion), but growth is slowing down.

This content was published on January 22, 2010 minutes

Cheaper prices, both for patented medicines and generics, were cited as the reason for the slowdown from the 5.5 per cent increase recorded in 2008.

The savings totalled more than SFr400 million, according to an analysis by IMS Health.

It said that the use of generics in hospitals had increased significantly, up 3.9 per cent to SFr449 million compared with the previous year.

IMS Health added that the pharmaceutical market could contract by between one and three per cent this year. and agencies

In compliance with the JTI standards

In compliance with the JTI standards

More: SWI certified by the Journalism Trust Initiative

Contributions under this article have been turned off. You can find an overview of ongoing debates with our journalists here. Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at

Share this story

Change your password

Do you really want to delete your profile?